161 related articles for article (PubMed ID: 24933703)
1. TMEPAI inhibits TGF-β signaling by promoting lysosome degradation of TGF-β receptor and contributes to lung cancer development.
Bai X; Jing L; Li Y; Li Y; Luo S; Wang S; Zhou J; Liu Z; Diao A
Cell Signal; 2014 Sep; 26(9):2030-9. PubMed ID: 24933703
[TBL] [Abstract][Full Text] [Related]
2. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
3. C18 ORF1, a novel negative regulator of transforming growth factor-β signaling.
Nakano N; Maeyama K; Sakata N; Itoh F; Akatsu R; Nakata M; Katsu Y; Ikeno S; Togawa Y; Vo Nguyen TT; Watanabe Y; Kato M; Itoh S
J Biol Chem; 2014 May; 289(18):12680-92. PubMed ID: 24627487
[TBL] [Abstract][Full Text] [Related]
4. TMEPAI regulates EMT in lung cancer cells by modulating the ROS and IRS-1 signaling pathways.
Hu Y; He K; Wang D; Yuan X; Liu Y; Ji H; Song J
Carcinogenesis; 2013 Aug; 34(8):1764-72. PubMed ID: 23615405
[TBL] [Abstract][Full Text] [Related]
5. TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling.
Watanabe Y; Itoh S; Goto T; Ohnishi E; Inamitsu M; Itoh F; Satoh K; Wiercinska E; Yang W; Shi L; Tanaka A; Nakano N; Mommaas AM; Shibuya H; Ten Dijke P; Kato M
Mol Cell; 2010 Jan; 37(1):123-34. PubMed ID: 20129061
[TBL] [Abstract][Full Text] [Related]
6. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis.
Wang HX; Sharma C; Knoblich K; Granter SR; Hemler ME
Cell Res; 2015 Mar; 25(3):370-85. PubMed ID: 25656846
[TBL] [Abstract][Full Text] [Related]
7. SNX25 regulates TGF-β signaling by enhancing the receptor degradation.
Hao X; Wang Y; Ren F; Zhu S; Ren Y; Jia B; Li YP; Shi Y; Chang Z
Cell Signal; 2011 May; 23(5):935-46. PubMed ID: 21266196
[TBL] [Abstract][Full Text] [Related]
8. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
9. TMEPAI/PMEPA1 enhances tumorigenic activities in lung cancer cells.
Vo Nguyen TT; Watanabe Y; Shiba A; Noguchi M; Itoh S; Kato M
Cancer Sci; 2014 Mar; 105(3):334-41. PubMed ID: 24438557
[TBL] [Abstract][Full Text] [Related]
10. TMEPAI family: involvement in regulation of multiple signalling pathways.
Itoh S; Itoh F
J Biochem; 2018 Sep; 164(3):195-204. PubMed ID: 29945215
[TBL] [Abstract][Full Text] [Related]
11. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
[TBL] [Abstract][Full Text] [Related]
12. Interaction of E3 Ubiquitin Ligase MARCH7 with Long Noncoding RNA MALAT1 and Autophagy-Related Protein ATG7 Promotes Autophagy and Invasion in Ovarian Cancer.
Hu J; Zhang L; Mei Z; Jiang Y; Yi Y; Liu L; Meng Y; Zhou L; Zeng J; Wu H; Jiang X
Cell Physiol Biochem; 2018; 47(2):654-666. PubMed ID: 29794480
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta (TGF-beta)-inducible gene TMEPAI converts TGF-beta from a tumor suppressor to a tumor promoter in breast cancer.
Singha PK; Yeh IT; Venkatachalam MA; Saikumar P
Cancer Res; 2010 Aug; 70(15):6377-83. PubMed ID: 20610632
[TBL] [Abstract][Full Text] [Related]
14. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
15. Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis.
Zeng T; Wang Q; Fu J; Lin Q; Bi J; Ding W; Qiao Y; Zhang S; Zhao W; Lin H; Wang M; Lu B; Deng X; Zhou D; Yin Z; Wang HR
Cell Rep; 2014 May; 7(3):871-82. PubMed ID: 24746824
[TBL] [Abstract][Full Text] [Related]
16. POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.
Wang B; Xu X; Yang Z; Zhang L; Liu Y; Ma A; Xu G; Tang M; Jing T; Wu L; Liu Y
EBioMedicine; 2019 Mar; 41():320-332. PubMed ID: 30745168
[TBL] [Abstract][Full Text] [Related]
17. TMEPAI increases lysosome stability and promotes autophagy.
Luo S; Yang M; Lv D; Jing L; Li Y; Liu Z; Diao A
Int J Biochem Cell Biol; 2016 Jul; 76():98-106. PubMed ID: 27163528
[TBL] [Abstract][Full Text] [Related]
18. Low density lipoprotein receptor class A domain containing 4 (LDLRAD4) promotes tumorigenesis of hepatic cancer cells.
Liu Z; Huo X; Zhao S; Yang J; Shi W; Jing L; Li W; Li Y; Ma L; Gao Y; Diao A
Exp Cell Res; 2017 Nov; 360(2):189-198. PubMed ID: 28888937
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitination and dynactin regulate TMEPAI lysosomal trafficking.
Luo S; Jing L; Zhao T; Li Y; Liu Z; Diao A
Sci Rep; 2017 Feb; 7():42668. PubMed ID: 28218281
[TBL] [Abstract][Full Text] [Related]
20. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation.
Seo SR; Lallemand F; Ferrand N; Pessah M; L'Hoste S; Camonis J; Atfi A
EMBO J; 2004 Oct; 23(19):3780-92. PubMed ID: 15359284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
